235 results on '"Herranz Pinto P"'
Search Results
2. Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
3. Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain
4. Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation
5. [Translated article] Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial
6. [Translated article] Retrospective Study of Risk Markers for Developing High-Grade Anal Intraepithelial Neoplasm in Men Who Have Sex With Men Living With HIV
7. [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo
8. Estudio retrospectivo que evalúa marcadores de riesgo de desarrollar lesión escamosa intraepitelial anal de alto grado en hombres que tiene sexo con hombres y viven con el virus de inmunodeficiencia humana
9. Carga clínica, psicosocial y económica de la dermatitis atópica en vida real: resultados de la cohorte española del estudio MEASURE-AD
10. Incorporación de resultados informados por pacientes con psoriasis y dermatitis atópica en las consultas de atención farmacéutica y dermatología: herramienta que mejora la calidad asistencial y resultados en salud
11. Líneas de mejora asistencial entre dermatólogos y farmacéuticos hospitalarios para el manejo y seguimiento de la dermatitis atópica: consenso Delphi
12. Infecciones de transmisión sexual (ITS) durante el estado de alarma por la pandemia de COVID-19 en España
13. Consenso sobre el algoritmo diagnóstico del prurigo crónico nodular
14. Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital
15. Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
16. EE408 Pharmacoeconomic Analysis of Abrocitinib in Patients with Severe Atopic Dermatitis Versus Systemic Treatments in Spain
17. [Translated article] Sexually Transmitted Infections During the First Wave of the COVID-19 Pandemic in Spain
18. [Translated article] Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists
19. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population
20. Consensus-Based Acne Classification System and Treatment Algorithm for Spain
21. Consenso español para establecer una clasificación y un algoritmo de tratamiento del acné
22. Urticarial exanthem as early diagnostic clue for COVID-19 infection
23. HTA3 The Clinical and Economic Value of a Sustained Response in the Treatment of Moderate-to-Severe Psoriasis in Spain: The PSOVALUE Project
24. [Translated article] Atypical Nodular Vasculitis—A Diagnostic Clue in Metastatic Melanoma
25. Vasculitis nodular de presentación atípica: la clave para el diagnóstico en un caso de melanoma metastásico
26. Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta‐analysis
27. Human monkeypox outbreak: epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study.
28. Ustekinumab. Análisis de efectos adversos infecciosos
29. Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
30. Infecciones de transmisión sexual (ITS) durante el estado de alarma por la pandemia de COVID-19 en España
31. [Translated article] Sexually Transmitted Infections During the First Wave of the COVID-19 Pandemic in Spain
32. Sexually Transmitted Infections During the First Wave of the COVID-19 Pandemic in Spain⋆
33. Infliximab Treatment of Psoriasis in Supervised Infusion Centers: Case Management Experience
34. Kaposi sarcoma secondary to endogenous adrenocorticotropic hormone-dependent Cushing syndrome
35. Successful treatment of refractory pruritic Fox–Fordyce disease with botulinum toxin type A
36. 50543 Upadacitinib Improves Atopic Dermatitis-Related Nighttime Itch and Reduces Sleep Disturbance: Analysis of Time Spent in Response State From the Integrated Phase 3 Measure Up 1/2 Clinical Trials.
37. WITHDRAWN: Sexually Transmitted Infections During the First Wave of the COVID-19 Pandemic in Spain
38. ¿Son las alteraciones en la mucosa oral un signo de COVID-19? Estudio transversal en un Hospital de Campaña
39. Pityriasis rosea, COVID‐19 and vaccination: new keys to understand an old acquaintance
40. Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID‐19 in a field hospital in Spain
41. Palmoplantar erythrodysesthesia: a diagnostic sign of COVID‐19
42. Vascular tumor on the forehead of an HIV patient
43. Cutaneous adverse events associated with heparin
44. Prevalence of mucocutaneous manifestations in 666 patients with COVID‐19 in a field hospital in Spain: oral and palmoplantar findings
45. Cutaneous small vessel vasculitis secondary to COVID‐19 infection: a case report
46. Erosive and crusty plaque located in the ear of a patient with a childhood burn history
47. Placa erosiva y costrosa auricular en paciente con antecedente de quemadura en la infancia
48. Effets à long terme du dupilumab sur les valeurs du SCORAD dans l’évaluation de la dermatite atopique modérée à sévère : résultats de l’étude de phase 3 LIBERTY AD CHRONOS
49. Sustained effect of dupilumab with concomital topical corticosteroids on healrh-related quality of life in patients with moderate-to-severe atopic dermatitis: liberty ad chronos
50. Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.